MLN9708 structure
|
Common Name | MLN9708 | ||
---|---|---|---|---|
CAS Number | 1201902-80-8 | Molecular Weight | 517.122 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C20H23BCl2N2O9 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid |
---|---|
Synonym | More Synonyms |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C20H23BCl2N2O9 |
Molecular Weight | 517.122 |
Exact Mass | 516.087341 |
PSA | 175.31000 |
LogP | 3.37810 |
Index of Refraction | 1.580 |
~95% MLN9708 CAS#:1201902-80-8 |
Literature: MILLENNIUM PHARMACEUTICALS, INC. Patent: WO2009/154737 A1, 2009 ; Location in patent: Page/Page column 63 ; |
Precursor 2 | |
---|---|
DownStream 0 |
MLN9708 |
cc-436 |
UNII:E8R04MBQ04 |
4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid |
S2181_Selleck |
1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo- |
Ixazomib Citrate |